← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 30, 2018Last known activity
Nov 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT05508074Overall official - principal investigatorPhase 2Nov 30, 2022
- NCT05384821Overall official - principal investigatorPhase 1/Phase 2May 31, 2022
- NCT04526353Overall official - principal investigatorPhase 2Sep 10, 2020
- NCT04235608Overall official - principal investigatorPhase 3Mar 30, 2020
- NCT03585465Study directorPhase 1/Phase 2Sep 30, 2018
- NCT03585465OfficialPhase 1/Phase 2Sep 30, 2018
Details
- Last known activity
- Nov 30, 2022